Regeneron Pharmaceuticals (REGN) Profit After Tax (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.90% |
| Dec 31, 2025 | -42.15% |
| Sep 30, 2025 | 4.92% |
| Jun 30, 2025 | 72.08% |
| Mar 31, 2025 | -11.88% |
| Dec 31, 2024 | -31.55% |
| Sep 30, 2024 | -6.40% |
| Jun 30, 2024 | 98.38% |
| Mar 31, 2024 | -37.74% |
| Dec 31, 2023 | 15.06% |
| Sep 30, 2023 | 4.07% |
| Jun 30, 2023 | 18.42% |
| Mar 31, 2023 | -31.68% |
| Dec 31, 2022 | -9.01% |
| Sep 30, 2022 | 54.41% |
| Jun 30, 2022 | -12.47% |
| Mar 31, 2022 | -56.33% |
| Dec 31, 2021 | 36.56% |
| Sep 30, 2021 | -47.33% |
| Jun 30, 2021 | 177.88% |
| Mar 31, 2021 | -2.96% |
| Dec 31, 2020 | 36.47% |
| Sep 30, 2020 | -6.15% |
| Jun 30, 2020 | 43.66% |
| Mar 31, 2020 | -21.14% |
| Dec 31, 2019 | 18.28% |
| Sep 30, 2019 | 246.76% |
| Jun 30, 2019 | -58.12% |
| Mar 31, 2019 | -43.80% |
| Dec 31, 2018 | 37.95% |
| Sep 30, 2018 | 7.85% |
| Jun 30, 2018 | 15.36% |
| Mar 31, 2018 | 175.50% |
| Dec 31, 2017 | -55.32% |
| Sep 30, 2017 | 0.15% |
| Jun 30, 2017 | 55.77% |
| Mar 31, 2017 | -1.67% |
| Dec 31, 2016 | -4.41% |
| Sep 30, 2016 | 34.95% |
| Jun 30, 2016 | 8.18% |
| Mar 31, 2016 | 17.03% |
| Dec 31, 2015 | -26.33% |
| Sep 30, 2015 | 8.09% |
| Jun 30, 2015 | 156.04% |
| Mar 31, 2015 | -15.62% |
| Dec 31, 2014 | 8.06% |
| Sep 30, 2014 | -13.47% |
| Jun 30, 2014 | 41.06% |
| Mar 31, 2014 | -29.44% |
| Dec 31, 2013 | -31.49% |
| Sep 30, 2013 | 61.72% |
| Jun 30, 2013 | -11.63% |
| Mar 31, 2013 | -78.98% |
| Dec 31, 2012 | 145.68% |
| Sep 30, 2012 | 149.49% |
| Jun 30, 2012 | 558.68% |
| Mar 31, 2012 | 121.80% |
| Dec 31, 2011 | 14.31% |
| Sep 30, 2011 | 0.22% |
| Jun 30, 2011 | -43.86% |
| Mar 31, 2011 | -197.64% |
| Dec 31, 2010 | 56.91% |
| Sep 30, 2010 | -32.98% |
| Jun 30, 2010 | 16.54% |
| Mar 31, 2010 | 16.35% |
| Dec 31, 2009 | -3,494.98% |
| Sep 30, 2009 | 93.21% |